LISA FRISBIE: Open Payments
NPI 1477262970 · COLUMBUS, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,159 in 53 payments from 8 companies in 2025. Trend: 2023 $65 · 2024 $488 · 2025 $1,159
Food & beverage: $1,155Education: $4
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $231 |
| E.R. Squibb & Sons, L.L.C. | 8 | $214 |
| Axsome Therapeutics, Inc. | 10 | $198 |
| Otsuka America Pharmaceutical, Inc. | 8 | $163 |
| Teva Pharmaceuticals USA, Inc. | 5 | $148 |
| ABBVIE INC. | 11 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
Products named: COBENFY, Auvelity, AUSTEDO XR, VRAYLAR, LYBALVI, REXULTI, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across KS — which companies pay providers there.
